Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronaviruses

Zhi Yong Yang, Heidi C. Werner, Wing Pui Kong, Kwanyee Leung, Elisabetta Traggiai, Antonio Lanzavecchia, Gary J. Nabel

Research output: Contribution to journalArticle

Abstract

Molecular characterization of the severe acute respiratory syndrome coronavirus has revealed genetic diversity among isolates. The spike (S) glycoprotein, the major target for vaccine and immune therapy, shows up to 17 substitutions in its 1,255-aa sequence; however, the biologic significance of these changes is unknown. Here, the functional effects of S mutations have been determined by analyzing their affinity for a viral receptor, human angiotensin-converting enzyme 2 (hACE-2), and their sensitivity to Ab neutralization with viral pseudotypes. Although minor differences among eight strains transmitted during human outbreaks in early 2003 were found, substantial functional changes were detected in S derived from a case in late 2003 from Guangdong province [S(GD03T0013)] and from two palm civets, S(SZ3) and S(SZ16). S(GD03T0013) depended less on the hACE-2 receptor and was markedly resistant to Ab inhibition. Unexpectedly, Abs that neutralized most human S glycoproteins enhanced entry mediated by the civet virus S glycoproteins. The mechanism of enhancement involved the interaction of Abs with conformational epitopes in the hACE-2-binding domain. Finally, improved immunogens and mAbs that minimize this complication have been defined. These data show that the entry of severe acute respiratory syndrome coronaviruses can be enhanced by Abs, and they underscore the need to address the evolving diversity of this newly emerged virus for vaccines and immune therapies.

Original languageEnglish (US)
Pages (from-to)797-801
Number of pages5
JournalProceedings of the National Academy of Sciences of the United States of America
Volume102
Issue number3
DOIs
StatePublished - Jan 18 2005
Externally publishedYes

Fingerprint

Severe Acute Respiratory Syndrome
Coronavirus
Viverridae
Active Immunotherapy
Glycoproteins
Antibodies
Viruses
Disease Outbreaks
Epitopes
Mutation
angiotensin converting enzyme 2

Keywords

  • Angiotensin-converting enzyme 2
  • Enhancement
  • Immunoglobulin G
  • Pseudovirus

ASJC Scopus subject areas

  • Genetics
  • General

Cite this

Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronaviruses. / Yang, Zhi Yong; Werner, Heidi C.; Kong, Wing Pui; Leung, Kwanyee; Traggiai, Elisabetta; Lanzavecchia, Antonio; Nabel, Gary J.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 102, No. 3, 18.01.2005, p. 797-801.

Research output: Contribution to journalArticle

Yang, Zhi Yong ; Werner, Heidi C. ; Kong, Wing Pui ; Leung, Kwanyee ; Traggiai, Elisabetta ; Lanzavecchia, Antonio ; Nabel, Gary J. / Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronaviruses. In: Proceedings of the National Academy of Sciences of the United States of America. 2005 ; Vol. 102, No. 3. pp. 797-801.
@article{a0562135a8d84362bd8402a16e90cbea,
title = "Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronaviruses",
abstract = "Molecular characterization of the severe acute respiratory syndrome coronavirus has revealed genetic diversity among isolates. The spike (S) glycoprotein, the major target for vaccine and immune therapy, shows up to 17 substitutions in its 1,255-aa sequence; however, the biologic significance of these changes is unknown. Here, the functional effects of S mutations have been determined by analyzing their affinity for a viral receptor, human angiotensin-converting enzyme 2 (hACE-2), and their sensitivity to Ab neutralization with viral pseudotypes. Although minor differences among eight strains transmitted during human outbreaks in early 2003 were found, substantial functional changes were detected in S derived from a case in late 2003 from Guangdong province [S(GD03T0013)] and from two palm civets, S(SZ3) and S(SZ16). S(GD03T0013) depended less on the hACE-2 receptor and was markedly resistant to Ab inhibition. Unexpectedly, Abs that neutralized most human S glycoproteins enhanced entry mediated by the civet virus S glycoproteins. The mechanism of enhancement involved the interaction of Abs with conformational epitopes in the hACE-2-binding domain. Finally, improved immunogens and mAbs that minimize this complication have been defined. These data show that the entry of severe acute respiratory syndrome coronaviruses can be enhanced by Abs, and they underscore the need to address the evolving diversity of this newly emerged virus for vaccines and immune therapies.",
keywords = "Angiotensin-converting enzyme 2, Enhancement, Immunoglobulin G, Pseudovirus",
author = "Yang, {Zhi Yong} and Werner, {Heidi C.} and Kong, {Wing Pui} and Kwanyee Leung and Elisabetta Traggiai and Antonio Lanzavecchia and Nabel, {Gary J.}",
year = "2005",
month = "1",
day = "18",
doi = "10.1073/pnas.0409065102",
language = "English (US)",
volume = "102",
pages = "797--801",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "3",

}

TY - JOUR

T1 - Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronaviruses

AU - Yang, Zhi Yong

AU - Werner, Heidi C.

AU - Kong, Wing Pui

AU - Leung, Kwanyee

AU - Traggiai, Elisabetta

AU - Lanzavecchia, Antonio

AU - Nabel, Gary J.

PY - 2005/1/18

Y1 - 2005/1/18

N2 - Molecular characterization of the severe acute respiratory syndrome coronavirus has revealed genetic diversity among isolates. The spike (S) glycoprotein, the major target for vaccine and immune therapy, shows up to 17 substitutions in its 1,255-aa sequence; however, the biologic significance of these changes is unknown. Here, the functional effects of S mutations have been determined by analyzing their affinity for a viral receptor, human angiotensin-converting enzyme 2 (hACE-2), and their sensitivity to Ab neutralization with viral pseudotypes. Although minor differences among eight strains transmitted during human outbreaks in early 2003 were found, substantial functional changes were detected in S derived from a case in late 2003 from Guangdong province [S(GD03T0013)] and from two palm civets, S(SZ3) and S(SZ16). S(GD03T0013) depended less on the hACE-2 receptor and was markedly resistant to Ab inhibition. Unexpectedly, Abs that neutralized most human S glycoproteins enhanced entry mediated by the civet virus S glycoproteins. The mechanism of enhancement involved the interaction of Abs with conformational epitopes in the hACE-2-binding domain. Finally, improved immunogens and mAbs that minimize this complication have been defined. These data show that the entry of severe acute respiratory syndrome coronaviruses can be enhanced by Abs, and they underscore the need to address the evolving diversity of this newly emerged virus for vaccines and immune therapies.

AB - Molecular characterization of the severe acute respiratory syndrome coronavirus has revealed genetic diversity among isolates. The spike (S) glycoprotein, the major target for vaccine and immune therapy, shows up to 17 substitutions in its 1,255-aa sequence; however, the biologic significance of these changes is unknown. Here, the functional effects of S mutations have been determined by analyzing their affinity for a viral receptor, human angiotensin-converting enzyme 2 (hACE-2), and their sensitivity to Ab neutralization with viral pseudotypes. Although minor differences among eight strains transmitted during human outbreaks in early 2003 were found, substantial functional changes were detected in S derived from a case in late 2003 from Guangdong province [S(GD03T0013)] and from two palm civets, S(SZ3) and S(SZ16). S(GD03T0013) depended less on the hACE-2 receptor and was markedly resistant to Ab inhibition. Unexpectedly, Abs that neutralized most human S glycoproteins enhanced entry mediated by the civet virus S glycoproteins. The mechanism of enhancement involved the interaction of Abs with conformational epitopes in the hACE-2-binding domain. Finally, improved immunogens and mAbs that minimize this complication have been defined. These data show that the entry of severe acute respiratory syndrome coronaviruses can be enhanced by Abs, and they underscore the need to address the evolving diversity of this newly emerged virus for vaccines and immune therapies.

KW - Angiotensin-converting enzyme 2

KW - Enhancement

KW - Immunoglobulin G

KW - Pseudovirus

UR - http://www.scopus.com/inward/record.url?scp=14144254155&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=14144254155&partnerID=8YFLogxK

U2 - 10.1073/pnas.0409065102

DO - 10.1073/pnas.0409065102

M3 - Article

C2 - 15642942

AN - SCOPUS:14144254155

VL - 102

SP - 797

EP - 801

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 3

ER -